Aprameya Engineering IPO

About Aprameya Engineering Limited

Aprameya Engineering Limited specialises in the installation, setup, and maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Paediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards. These services are provided on a turnkey basis, including the supply of high-value healthcare and diagnostic equipment to private and government hospitals as well as medical practitioners.

Starting as a partnership firm on September 5, 2003, Aprameya Engineering Limited has evolved to offer comprehensive healthcare solutions. With a deep understanding of medical practitioners' needs and industry standards, the company provides end-to-end solutions for ICU and operation theatre setups, along with medical equipment that aids in patient treatment, monitoring, and diagnosis.

Since 2020, the company has expanded its business to include turnkey healthcare infrastructure solutions. This includes designing and installing modular and prefabricated operation theatres, ICUs, and other critical care environments. The company's product portfolio includes high-value medical equipment such as ventilators, patient monitoring systems, critical care equipment, and diagnostic tools.

Aprameya Engineering Limited serves as a dealer for prominent medical equipment manufacturers like Johnson & Johnson Private Limited, Draeger India Private Limited, Philips India Limited, and Siemens Healthcare Private Limited. Over the years, the company has built a wide customer base, including private and government hospitals, medical colleges, and diagnostic service providers across the country. The company has completed numerous projects, including the installation of 1181 critical care beds in Rajasthan, amounting to over ₹12,000 lakh.

The company is led by experienced promoters Saurabh Kishorbhai Bhatt and Chetan Mohan Joshi, who bring over 18 years of expertise in high-value medical equipment. Their knowledge has driven the company's growth and financial performance, demonstrated by significant revenue increases between Fiscal 2020 and Fiscal 2022. Aprameya Engineering Limited continues to deliver healthcare infrastructure solutions and high-value medical equipment, ensuring cost-effectiveness and improved accessibility for the healthcare sector.

Industry Outlook:

1. Indian healthcare sector growing at 22% CAGR, creating 2.7 million new jobs by 2022. Increased demand for medical devices benefits Aprameya Engineering.
2. FDI inflows rose from USD 2.5 billion (2000-2001) to USD 50 billion (2019-2020). Government incentives boost domestic production, favouring Aprameya Engineering.
3. The healthcare industry is expected to reach $370 billion by 2025. Expanding infrastructure offers lucrative opportunities for Aprameya Engineering's ICU setups and diagnostic products.

Aprameya Engineering Limited IPO Objectives

The company plans to allocate the net proceeds from the issuance to the following purposes:

1. Utilise ₹7,000 lakh to boost operational efficiency and support long-term capital needs.
2. Allocating the remaining funds for issue-related expenses and general corporate purposes.

Peer Details

As per RHP, there are no listed companies in India that engage in a business similar to Aprameya Engineering Limited.

How to Check the Allotment Status of the Aprameya Engineering Limited IPO?

Steps to check IPO allotment status on Angel One’s app:

• Log in to the Angel One app
• Go to the individual order details page of the IPO that you had applied for.
• Check the IPO allotment status. As such, Angel One will notify you of your IPO allotment status via push notification, email, and SMS.

Contact Details of Aprameya Engineering Limited IPO

• Registered office: 908, 9th Floor, Venus Atlantis Corporate Park, Anandnagar, Prahlad Nagar, Ahmedabad, Gujarat 380015 India.
• Phone: + 079-40068827
• E-mail: cs@aelhealth.com